Orangelight - Company finances
- The company has not submitted financial data for these years: 2023.
|
EUR
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 3,163 | 35,685 |
| Profit before tax | 965 | - |
| Net profit | 965 | -2,592 |
| Equity | 24,962 | 22,370 |
| Liabilities | 316 | 5,549 |
| Non-current assets | 0 | 0 |
| Current assets | 25,278 | 27,919 |
| Total assets | 25,278 | 27,919 |
|
Taxes paid
|
||
| STI taxes | 1,374 | 4,562 |
|
Financial indicators
|
||
| Revenue change y/y | - | +1028.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.8% | -9.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 3.9% | -11.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 30.5% | -7.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 30.5% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Orangelight - Social security debts
The company had no debts to Sodra
Orangelight - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-01 | 2026-07-07 | 402.49 |
| 2026-06-28 | 2026-06-30 | 400.74 |
| 2026-06-01 | 2026-06-27 | 196.74 |
| 2026-05-31 | 2026-05-31 | 195.89 |
| 2026-05-22 | 2026-05-30 | 195.98 |
| 2026-05-15 | 2026-05-21 | 208.98 |
| 2026-05-06 | 2026-05-14 | 207.79 |
| 2026-05-01 | 2026-05-05 | 495.39 |
| 2026-04-30 | 2026-04-30 | 495.0 |
| 2026-03-28 | 2026-04-14 | 9.74 |
| 2026-03-22 | 2026-03-27 | 1984.59 |
| 2026-03-20 | 2026-03-21 | 2010.0 |
| 2026-03-11 | 2026-03-17 | 1993.0 |
| 2026-03-02 | 2026-03-10 | 1992.31 |
| 2026-02-21 | 2026-03-01 | 1987.21 |
| 2026-02-03 | 2026-02-20 | 1978.03 |
| 2026-01-31 | 2026-02-02 | 1971.92 |
| 2026-01-29 | 2026-01-30 | 1993.6 |
| 2026-01-13 | 2026-01-28 | 0.6 |
| 2026-01-09 | 2026-01-12 | 1093.82 |
| 2026-01-01 | 2026-01-08 | 1172.9 |
| 2025-10-23 | 2025-10-23 | 3.3 |
| 2025-10-08 | 2025-10-22 | 1.5 |
| 2025-10-02 | 2025-10-07 | 1169.55 |
| 2025-09-28 | 2025-10-01 | 1168.05 |
| 2025-06-19 | 2025-06-23 | 49.05 |
| 2025-06-02 | 2025-06-18 | 1.05 |
| 2025-05-31 | 2025-06-01 | 0.93 |
| 2025-05-28 | 2025-05-30 | 107.17 |
| 2025-05-24 | 2025-05-27 | 106.39 |
| 2025-05-01 | 2025-05-23 | 119.39 |
| 2025-04-28 | 2025-04-30 | 118.92 |
| 2025-04-02 | 2025-04-27 | 1.92 |
| 2025-03-28 | 2025-04-01 | 1179.61 |
| 2025-03-17 | 2025-03-27 | 1.61 |
| 2025-03-05 | 2025-03-16 | 0.69 |
| 2025-03-02 | 2025-03-04 | 860.41 |
| 2025-02-28 | 2025-03-01 | 858.36 |
| 2025-02-05 | 2025-02-27 | 1.36 |
| 2025-02-02 | 2025-02-04 | 1260.72 |
| 2025-01-30 | 2025-02-01 | 1259.36 |
| 2024-07-01 | 2024-10-16 | 3.36 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Orangelight, MB (code 306036732) is a Lithuanian small partnership engaged in the retail sale of other medical and orthopaedic goods. In 2025, the latest financial year, the company generated revenue of €35.7K, compared with €3.2K in 2024, showing a very strong expansion in turnover from a low base. However, profitability weakened: net profit moved from €965 in 2024 to a net loss of €2.6K in 2025, and the profit margin turned negative at -7.3%. Over the two-year period, revenue rose sharply while earnings deteriorated, indicating that growth did not translate into improved results. At the end of 2025, total assets were €27.9K, equity €22.4K and liabilities €5.5K. The balance sheet remained strongly equity-funded, with an equity ratio of 80.1% and debt to equity of 0.25. Efficiency indicators were moderate, with asset turnover at 1.28x, while ROE was -11.6% and ROA -9.3% in 2025. The company remained financially stable in structure, but profitability was under pressure.